Kforce Government Solutions Wins U.S. Army Achievement Award for TraumaFX(TM) MATT(TM)

Medical Training Simulator Selected as Winner From 471 Nominated Projects


WASHINGTON and TAMPA, Fla., May 26, 2010 (GLOBE NEWSWIRE) -- Kforce Government Solutions (KGS), a wholly-owned subsidiary of Kforce Inc. (Nasdaq:KFRC), has been awarded a prestigious U.S. Army Small Business Innovation Research (SBIR) Achievement Award for the development and commercialization of the TraumaFX™ Multiple Amputation Trauma Trainer (MATT)™. MATT is a dramatically realistic medical simulator engineered to improve training for the treatment of severe blast injuries. It began as a small business research project at dNovus RDI prior to the company's acquisition by KGS, and is now available for purchase by military and civilian agencies.

In an extremely competitive process, SBIR Achievement Awards recognize exceptional Phase II projects for their overall progress, innovation, technological impact on the Soldier, and commercialization potential. This year, 471 projects were nominated; TraumaFX MATT was one of only 11 selected to receive an award.

"We are incredibly proud to be recognized by the Army for the development of MATT, and equally proud to have created a technology that is being widely adopted and will directly contribute to saving lives in the field," said Larry Grant, President of KGS.

The 2010 awards were presented Monday by Dr. Thomas H. Killion, Deputy Assistant Secretary of the Army for Research and Technology/Chief Scientist during a ceremony at the Pentagon Conference Center in Washington, DC. Larry Grant, President of KGS and Dr. Thomas Bevan, Vice President of Research and Development, accepted on behalf of KGS.

"It is a rewarding experience to work on a project to help improve medical care for those in need. We're grateful for having had the opportunity to participate in this with the Army, and truly honored by the award from SBIR," explained Dr. Bevan. "We look forward to continuing our work and developing new TraumaFX products to address a wide range of medical training challenges."

TraumaFX™ is a line of ruggedized, tetherless training manikins engineered to deliver unparalleled realism for more authentic training. Products provide powerful visual and tactile simulations of severe trauma injuries, lifelike physiological responses to treatment, and the crucial ability to train in realistic environmental conditions and situations. The product line includes the Multiple Amputation Trauma Trainer (MATT)™, a lower-body simulator that replicates severe blast injuries such as those caused by IED explosions. MATT was jointly developed by dNovus RDI (now KGS) and the U.S. Army Simulation and Training Technology Center. Additional TraumaFX products targeted at improving the effectiveness and timeliness of care under fire and point of impact medical support are currently in research and development. More information can be found at www.kforcegov.com/traumafx.

About Kforce Government Solutions

Kforce Government Solutions, a wholly-owned subsidiary of Kforce Inc. (Nasdaq:KFRC) is a government contracting services provider that has offered a comprehensive portfolio of solutions to a wide range of Federal and Defense agencies since 1970. Headquartered in Fairfax, VA with offices in San Antonio, TX and Tampa, FL, the company today offers full-spectrum solutions in the areas of Finance and Accounting, Enterprise Technology Engineering and Operations, Healthcare Informatics, and Research and Development. For more information, visit www.kforcegov.com.

About Kforce

Kforce (Nasdaq:KFRC) is a professional staffing firm providing flexible and permanent staffing solutions for commercial and governmental organizations in the skill areas of technology, finance & accounting, and health and life sciences. Backed by over 2,000 staffing specialists, Kforce operates with 57 offices in 41 markets in North America and two in the Philippines. For more information, please visit our Web site at www.kforce.com.

The Kforce Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3749

Patent pending. KGS, TraumaFX, Multiple Amputation Trauma Trainer, and MATT are trademarks or registered trademarks of Kforce Government Solutions, Inc. Kforce is a registered trademark of Kforce, Inc. Other company, product, or service names may be trademarks or service marks of others.

Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. Factors that could cause actual results to differ materially include the following: business conditions and growth in the staffing industry and general economy; competitive factors, risks due to shifts in the market demand, including, without limitation, shifts in demand for our Technology, Finance and Accounting, Health and Life Sciences and Government Solutions segments, as well as the market for search and flexible staffing assignments; changes in the service mix; ability of the Firm to complete acquisitions; and the risk factors listed from time to time in the Firm's reports filed with the Securities and Exchange Commission, as well as assumptions regarding the foregoing. In particular, there can be no assurance that we will continue to increase our market share, successfully manage risks to our revenue stream and successfully put into place the people and processes that will create future success. The words "should," "believe," "estimate," "expect," "intend," "anticipate," "foresee," "plan" and similar expressions and variations thereof identify certain of such forward-looking statements, which speak only as of the dates on which they were made. The Firm undertakes no obligation to publicly update or revise any forward-looking statements. As a result, such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those indicated in the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements.



            

Contact Data

GlobeNewswire